Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus

Digestive Diseases

Volumn 26, Issue 3, 2008, Pages 243-247

  Neumann, Helmut ^a   Mönkemüller, Klaus ^a   Kandulski, Arne ^a   Malfertheiner, Peter ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Barrett; Dyspepsia; Erosive reflux disease; Gastroesophageal reflux disease; Irritable bowel syndrome; Non erosive reflux disease

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BLOATING; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE CLASSIFICATION; DYSPEPSIA; ENTERITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BARRETT ESOPHAGUS; COMORBIDITY; DYSPEPSIA; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 43449129462     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121354     Document Type: Article

References (21)

1. Longstreth GF, Drossman DA: Severe irritable bowel and functional abdominal pain syndromes: managing the patient and health care costs. Clin Gastroenterol Hepatol 2005;3:397-400.
2. Malfertheiner P: Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol 1999;11:25-29.
3. Zimmerman J, Hershcovici T: Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux. J Clin Gastroenterol 2008;42:261-265.
4. Fry LC, Mönkemüller K, Malfertheiner P: Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions - a debate: con. Curr Treat Options Gastroenterol 2007;10:305-311.
5. Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
6. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P: Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-57.
7. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R;Global Consensus Group: The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
8. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
9. Aanen MC, Numans ME, Weusten BL, Smout AJ: Diagnostic value of the Reflux Disease Questionnaire in general practice. Digestion 2006;74:162-168.
10. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
11. Locke GR III, Zinsmeister AR, Fett SL, Melton LJ III, Talley NJ: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34.
12. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ: Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007;26:453-461.
13. Smart HL, Nicholson DA, Atkinson M: Gastro-oesophageal reflux in the irritable bowel syndrome. Gut 1986;27:1127-1131.
14. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M: Studying the overlap between IBS and GERD: A systematic review of the literature. Dig Dis Sci 2006;51:2113-2120.
15. Dickman R, Feroze H, Fass R: Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome. Curr Gastroenterol Rep 2006;8:261-265.
16. Wu JC, Cheung CM, Wong VW, Sung JJ: Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol 2007;5:690-695.
17. Nojkov B, Rubenstein J, Adlis S, Shaw M, Saad R, Rai J, Weinman B, Chey WD: Predictors of response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: The impact of co-morbidities on treatment outcomes and quality of life. Aliment Pharmacol Ther 2008 [Epub ahead of print].
18. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA: Review article: from gastrin to gastro-oesophageal reflux disease - a century of acid suppression. Aliment Pharmacol Ther 2006;23:683-690.
19. Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN: Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study. Aliment Pharmacol Ther 2007;25:715-722.
20. Pogromov AP, Diukova GM, Rykova SM, Bein AM: Psycho-autonomic aspects in patients with gastroesophageal reflux disease, and functional esophageal disorders. Klin Med 2005;83:41-44.
21. Fass R: Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 2007;67:1521-1530.